Summary
Bristol-Myers Squibb Company (BMY) filed an 8-K on April 28, 2011, to report its financial results for the first quarter of 2011. The filing primarily serves to announce the release of a press release detailing these results and includes supplemental information available on the company's website. Investors seeking specific financial performance details, such as revenue, earnings per share, and divisional performance, should refer to the furnished press release (Exhibit 99.1) and supplemental data (Exhibit 99.2) for comprehensive information. This report itself does not contain the detailed financial figures but acts as a formal notification and public disclosure mechanism for the company's quarterly earnings announcement. Therefore, the key takeaways for investors lie in the availability of these more detailed financial reports and the date of their release, which is crucial for understanding the company's recent operational and financial condition.
Key Highlights
- 1BMY filed an 8-K on April 28, 2011, to announce its Q1 2011 financial results.
- 2The filing's primary purpose is to make public the company's financial performance for the first quarter of 2011.
- 3Exhibit 99.1 contains the official press release detailing the Q1 2011 financial results.
- 4Exhibit 99.2 includes supplemental financial information available on BMY's website.
- 5This report serves as formal disclosure of the earnings announcement date.
- 6Investors need to consult the referenced exhibits for specific financial data and performance metrics.
- 7The filing indicates the company is adhering to timely disclosure requirements for material events.